Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dev Biol ; 411(2): 217-230, 2016 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-26851213

RESUMO

The Chromatin Accessibility Complex (CHRAC) consists of the ATPase ISWI, the large ACF1 subunit and a pair of small histone-like proteins, CHRAC-14/16. CHRAC is a prototypical nucleosome sliding factor that mobilizes nucleosomes to improve the regularity and integrity of the chromatin fiber. This may facilitate the formation of repressive chromatin. Expression of the signature subunit ACF1 is restricted during embryonic development, but remains high in primordial germ cells. Therefore, we explored roles for ACF1 during Drosophila oogenesis. ACF1 is expressed in somatic and germline cells, with notable enrichment in germline stem cells and oocytes. The asymmetrical localization of ACF1 to these cells depends on the transport of the Acf1 mRNA by the Bicaudal-D/Egalitarian complex. Loss of ACF1 function in the novel Acf1(7) allele leads to defective egg chambers and their elimination through apoptosis. In addition, we find a variety of unusual 16-cell cyst packaging phenotypes in the previously known Acf1(1) allele, with a striking prevalence of egg chambers with two functional oocytes at opposite poles. Surprisingly, we found that the Acf1(1) deletion--despite disruption of the Acf1 reading frame--expresses low levels of a PHD-bromodomain module from the C-terminus of ACF1 that becomes enriched in oocytes. Expression of this module from the Acf1 genomic locus leads to packaging defects in the absence of functional ACF1, suggesting competitive interactions with unknown target molecules. Remarkably, a two-fold overexpression of CHRAC (ACF1 and CHRAC-16) leads to increased apoptosis and packaging defects. Evidently, finely tuned CHRAC levels are required for proper oogenesis.


Assuntos
Proteínas de Drosophila/fisiologia , Drosophila melanogaster/fisiologia , Nucleossomos/metabolismo , Oogênese , Fatores de Transcrição/fisiologia , Alelos , Animais , Apoptose , Montagem e Desmontagem da Cromatina , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Hibridização In Situ , Masculino , Oócitos/citologia , Oócitos/metabolismo , Ovário/metabolismo , Fenótipo , Estrutura Terciária de Proteína , RNA Interferente Pequeno/metabolismo , Células-Tronco/citologia
2.
Cell Rep ; 7(2): 321-330, 2014 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-24703848

RESUMO

Chromatin reorganization and the incorporation of specific histone modifications during DNA damage response are essential steps for the successful repair of any DNA lesion. Here, we show that the histone-fold protein CHRAC14 plays an essential role in response to DNA damage in Drosophila. Chrac14 mutants are hypersensitive to genotoxic stress and do not activate the G2/M cell-cycle checkpoint after damage induction. Even though the DNA damage repair process is activated in the absence of CHRAC14, lesions are not repaired efficiently. In the absence of CHRAC14, the centromere-specific histone H3 variant CENP-A localizes to sites of DNA damage, causing ectopic kinetochore formation and genome instability. CENP-A and CHRAC14 are able to interact upon damage. Our data suggest that CHRAC14 modulates chromatin composition in response to DNA damage, which is required for efficient DNA damage repair in Drosophila.


Assuntos
Cromatina/metabolismo , Dano ao DNA , Proteínas de Drosophila/metabolismo , Drosophila/metabolismo , Nucleoproteínas/metabolismo , Animais , Autoantígenos/metabolismo , Proteína Centromérica A , Proteínas Cromossômicas não Histona/metabolismo , Reparo do DNA , Drosophila/genética , Proteínas de Drosophila/genética , Pontos de Checagem da Fase G2 do Ciclo Celular , Instabilidade Genômica , Cinetocoros/metabolismo , Nucleoproteínas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA